SOLENO THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Soleno Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
  • Soleno Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $56.6M, a 2471% increase year-over-year.
  • Soleno Therapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $72.1M, a 1445% increase year-over-year.
  • Soleno Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.95M, a 135% increase from 2022.
  • Soleno Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.53M, a 22.8% decline from 2021.
  • Soleno Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $3.28M, a 118% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $72.1M $56.6M +$54.4M +2471% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $17.7M $7.16M +$5.96M +495% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $11.8M $6.45M +$5.81M +921% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.95M $1.91M +$1.28M +202% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $4.67M $2.2M +$1.52M +222% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $3.15M $1.2M +$633K +111% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.52M $631K -$13K -2.02% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.53M $632K +$214K +51.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $2.32M $683K -$223K -24.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.54M $571K -$286K -33.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.83M $644K -$451K -41.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.28M $418K +$25K +6.36% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $3.25M $906K +$532K +142% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.72M $857K +$516K +151% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $2.2M $1.1M +$703K +179% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.5M $393K +$143K +57.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.36M $374K +$221K +144% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.14M $341K +$121K +55% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $1.02M $392K +$190K +94.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $825K $250K -$261K -51.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $1.09M $153K -$78K -33.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.16M $220K +$21K +10.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.14M $202K -$157K -43.7% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $1.3M $511K +$365K +250% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 $935K $231K +$5K +2.21% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $930K $199K -$244K -55.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.17M $359K +$174K +94.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $1M $146K -$165K -53.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-20
Q3 2017 $1.17M $226K +$20K +9.71% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.15M $443K +$225K +103% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $920K $185K +$49K +36% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $871K $311K +$115K +58.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $756K $206K +$62K +43.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $694K $218K +$17K +8.46% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $677K $136K -$265K -66.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $942K $196K -$128K -39.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $1.07M $144K +$139K +2780% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $931K $201K +$196K +3920% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $735K $401K +$390K +3545% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-08-09
Q4 2014 $345K $324K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 $5K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $5K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $11K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.